Patterson Companies (PDCO) has agreed to acquire Animal Health International, an animal health distribution company in the United States. According to an announcement made by the company Monday, this acquisition will more than double the size of Patterson’s veterinary business. Under terms of the definitive agreement, Patterson Companies will acquireRead More

DuPont (DD) Tuesday reported lower profits for Q1 ended March 31, albeit better than analysts’ forecast, as sales dropped year-over-year due to impacts from currency, portfolio changes, and near-term industry-wide challenges in agriculture and performance chemicals. The chemical company said operating earnings were $1.2 billion, or $1.34 per share, aRead More

Applied Optoelectronics (AAOI) expects Q1 revenue in the range of $30 to $30.3 million, below its prior guidance of $35 to $36.5 million and south of the analyst consensus of $35.5 million on Capital IQ. “We are very disappointed to report preliminary revenue results below our expectations. Our first quarterRead More

Performance Sports Group (PSG) edged higher in extended trading after the maker of sports equipment and apparel reported stronger adjusted earnings as revenue more than doubled in its fiscal third quarter. Shares of the Exeter, New Hampshire-based company rose as much as 0.3% after gaining 5.5% to $19.74 at theRead More

Builders FirstSource (BLDR) shares soared 60% to a fresh seven-and-a-half-year high after resuming trade Monday as the maker of structural and related building products said it agreed to acquire building-materials supplier ProBuild Holdings in an all-cash transaction valued at approximately $1.63 billion. Recently shares were up on heavy volume ofRead More

Cytori Therapeutics (CYTX), a company that develops cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects, reported promising preliminary 12 month follow-up data from the 12 patient investigator initiated Scleradec-I clinical trial of Cytori’s ECCS-50 therapeutic. ECCS-50 is a cellular therapeuticRead More